Kira Pharmaceuticals

Kira Pharmaceuticals is a biotech company in Cambridge, United States, founded in 2017. It has 3 recorded funding rounds, most recently a Series B in January 2021.

Kira Homepage

Employees
11–50
Founded
2017
Business Model
B2B
Last Round
Series BJan 2021
Rounds
3

Indexed holds 3 funding rounds and 8 investors for this company. The full record is or through the API.

About

Kira Pharmaceuticals is a clinical-stage global biotechnology company founded in 2017, headquartered in Cambridge, Massachusetts with offices in Suzhou and Shanghai, China, and Australia. The company is pioneering treatments for complement-mediated diseases using its proprietary LOGIC (Lead identification, Optimization and Attribute Generation, In-vivo Confirmation) platform. Since inception, Kira has built a robust pipeline of nine novel complement assets. The company's leadership team includes co-founders Wenru Song (President & Head of R&D) and Gonghua Pan, along with drug developers, protein engineers, and world-renowned complement biology experts.

Summary

It lists 11–50 employees. Its most recent funding was a Series B round in Jan 2021. Investors include Quan Capital, RA Capital Management and Vivo Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BJan 2021

Sign up to see all 3 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kira Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/kira-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/kira-pharmaceuticals" alt="Kira Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>